BRCA1/BRCA2 rearrangements and CHEK2 common mutations are infrequent in Italian male breast cancer cases
- PMID: 17661168
- DOI: 10.1007/s10549-007-9689-2
BRCA1/BRCA2 rearrangements and CHEK2 common mutations are infrequent in Italian male breast cancer cases
Abstract
Male breast cancer (MBC) is a rare and poorly known disease. Germ-line mutations of BRCA2 and, to lesser extent, BRCA1 genes are the highest risk factors associated with MBC. Interestingly, BRCA2 germ-line rearrangements have been described in high-risk breast/ovarian cancer families which included at least one MBC case. Germ-line mutations of CHEK2 gene have been also implicated in inherited MBC predisposition. The CHEK2 1100delC mutation has been shown to increase the risk of breast cancer in men lacking BRCA1/BRCA2 mutations. Intriguingly, two other CHEK2 mutations (IVS2+1G>A and I157T) and a CHEK2 large genomic deletion (del9-10) have been associated with an elevated risk for prostate cancer. Here, we investigated the contribution of BRCA1, BRCA2 and CHEK2 alterations to MBC predisposition in Italy by analysing a large series of MBC cases, unselected for breast cancer family history and all negative for BRCA1/BRCA2 germ-line mutations. A total of 102 unrelated Italian MBC cases were screened for deletions/duplications of BRCA1, BRCA2 and CHEK2 by multiplex ligation-dependent probe amplification. No BRCA1, BRCA2 and CHEK2 genomic rearrangements, including the CHEK2 del9-10, were found in the series analysed. Furthermore, none of the MBC cases and 263 male population controls, also included in this study, carried the CHEK2 1100delC, IVS2+1G>A and I157T common mutations. Overall, our data suggest that screening of BRCA1/2 rearrangements is not advantageous in MBC cases not belonging to high-risk breast cancer families and that common CHEK2 mutations play an irrelevant role in MBC predisposition in Italy.
Similar articles
-
Large genomic BRCA2 rearrangements and male breast cancer.Cancer Detect Prev. 2006;30(6):530-4. doi: 10.1016/j.cdp.2006.10.002. Epub 2006 Nov 20. Cancer Detect Prev. 2006. PMID: 17113724
-
CHEK2 1100delC and male breast cancer in the Netherlands.Breast Cancer Res Treat. 2009 Jul;116(2):397-400. doi: 10.1007/s10549-008-0162-7. Epub 2008 Aug 31. Breast Cancer Res Treat. 2009. PMID: 18759107
-
BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy.Cancer Res. 2003 Jan 15;63(2):342-7. Cancer Res. 2003. PMID: 12543786
-
CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls.J Clin Oncol. 2008 Feb 1;26(4):542-8. doi: 10.1200/JCO.2007.12.5922. Epub 2008 Jan 2. J Clin Oncol. 2008. PMID: 18172190 Review.
-
Pitfalls and caveats in BRCA sequencing.Ultrastruct Pathol. 2006 May-Jun;30(3):229-35. doi: 10.1080/01913120500521281. Ultrastruct Pathol. 2006. PMID: 16825125 Review.
Cited by
-
Association Between CHEK2*1100delC and Breast Cancer: A Systematic Review and Meta-Analysis.Mol Diagn Ther. 2018 Aug;22(4):397-407. doi: 10.1007/s40291-018-0344-x. Mol Diagn Ther. 2018. PMID: 29909568
-
Gender-Specific Genetic Predisposition to Breast Cancer: BRCA Genes and Beyond.Cancers (Basel). 2024 Jan 30;16(3):579. doi: 10.3390/cancers16030579. Cancers (Basel). 2024. PMID: 38339330 Free PMC article. Review.
-
Gender Medicine in Clinical Radiology Practice.J Pers Med. 2023 Jan 27;13(2):223. doi: 10.3390/jpm13020223. J Pers Med. 2023. PMID: 36836457 Free PMC article. Review.
-
Gene copy number variation in male breast cancer by aCGH.Cell Oncol (Dordr). 2011 Oct;34(5):467-73. doi: 10.1007/s13402-011-0041-9. Epub 2011 May 6. Cell Oncol (Dordr). 2011. PMID: 21547577
-
The BRCAPRO 5.0 model is a useful tool in genetic counseling and clinical management of male breast cancer cases.Eur J Hum Genet. 2010 Jul;18(7):856-8. doi: 10.1038/ejhg.2010.29. Epub 2010 Mar 17. Eur J Hum Genet. 2010. PMID: 20234394 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous